Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions (Details)

v3.8.0.1
Related Party Transactions (Details) - MSKCC [Member]
9 Months Ended
Sep. 30, 2017
USD ($)
New Drug Application [Member]  
Summary of milestone payments related to related party  
Milestone payments $ 750,000
Receipt of Regulatory Approval From U.S. FDA [Member]  
Summary of milestone payments related to related party  
Milestone payments $ 1,750,000